Full-Time
Staff Platform Engineer
Confirmed live in the last 24 hours
Twist Bioscience
1,001-5,000 employees
Produces synthetic DNA for biotechnology applications
Senior, Expert
Remote in USA
- Bachelor’s or Master’s degree in Computer Science, Engineering, or a related field.
- Minimum of 8 years of experience in software engineering, with a focus on platform engineering, system architecture, and systems integration.
- Proficient in Java and Python.
- Extensive experience with system architecture and design.
- Develop and maintain the architecture of complex systems, ensuring they are scalable, robust, and meet business requirements.
- Design and implement integrations between various systems and platforms, ensuring seamless data flow and interoperability.
- Create and maintain RESTful APIs, ensuring they are well-documented, secure, and performant.
- Work with big data technologies such as Amazon EMR to process and analyze large datasets, ensuring data is readily available for analytics and decision-making.
- Write clean, maintainable, and efficient code in Java and Python. Conduct code reviews to ensure adherence to best practices and quality standards.
- Collaborate with cross-functional teams, including product managers, data scientists, and other engineers, to deliver high-quality solutions. Provide technical leadership and mentorship to junior engineers.
- Continuously monitor and optimize system performance, identifying and addressing bottlenecks and performance issues.
- Ensure that all systems and integrations adhere to security best practices and comply with relevant regulations and standards.
Twist Bioscience focuses on DNA synthesis, providing synthetic DNA for applications in biotechnology, pharmaceuticals, and research. Their proprietary platform allows for quick and accurate production of DNA sequences, offering products like genes, oligo pools, and variant libraries. The company stands out by delivering high-quality DNA at competitive prices and can handle complex sequences, making it a valuable partner for research projects. Twist Bioscience aims to support advancements in science and medicine through accessible DNA synthesis.
Company Stage
IPO
Total Funding
$585.6M
Headquarters
San Francisco, California
Founded
2013
6 month growth
↓ -1%1 year growth
↑ 0%2 year growth
↑ 3%
Simplify's Take
What believers are saying
- The launch of new products like CHO Express Antibodies and synthetic RNA controls for H5N1 Influenza A demonstrates Twist Bioscience's commitment to innovation and expanding its product portfolio.
- Significant investments from firms like Brown Advisory Inc. and Dynamic Technology Lab Private Ltd highlight strong market confidence in Twist Bioscience's growth potential.
- Collaborations with companies like Oxford Nanopore Technologies to advance personalized medicine underscore Twist Bioscience's influence in cutting-edge biotechnological research.
What critics are saying
- The rapidly evolving synthetic biology and genomics sector requires continuous innovation, which can be resource-intensive and challenging to sustain.
- High competition in the DNA synthesis market could pressure Twist Bioscience to continually lower prices, potentially impacting profit margins.
What makes Twist Bioscience unique
- Twist Bioscience's proprietary platform allows for rapid and accurate DNA synthesis, providing instant feedback to customers, which is a significant advantage over traditional methods.
- Their ability to handle complex DNA sequences that are difficult to work with makes them a valuable partner for advanced research projects.
- Twist Bioscience offers a diverse range of products, including synthetic RNA controls and DNA data storage solutions, setting them apart from competitors who may focus on narrower product lines.